Home

Rep. Hank Johnson, D-Ga., has revealed that he has hepatitis C, a serious liver disease that can lead to fatal complications such as cancer or liver failure. In recent months, the 55-year-old Johnson has appeared thin and frail. The two-term Atlanta-area congressman said in a statement that ...

An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said Thursday. The treatment works by inhibiting a molecule that helps hepatitis C virus replicate, according to scientists at the Southwest Foundation for Biomedical Research (SFBR), who said the drug continued ...

Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C. An independent committee reviewed data from the first 100 subjects enrolled in the midstage study, which compares a combination ...

Vertex Pharmaceuticals Inc. said Wednesday its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had not been helped by other drugs. The results came from a midstage trial of the experimental drug. Vertex said a majority of patients ...

NEW YORK (Reuters Health) - A few cups of coffee everyday may help slow the progression of liver disease associated with long-term infection with the hepatitis C virus, a new study hints. Researchers found that among 766 patients with hepatitis C-related liver damage, those who drank three or more cups of coffee per day were 53 percent less likely than non-drinkers ...

Researchers in the United States have found another good reason to go to the local espresso bar: several cups of coffee a day could halt the progression of liver disease, a study showed Wednesday. Sufferers of chronic hepatitis C and advanced liver disease who drank three or more cups of coffee per day slashed their risk of the disease progressing ...

A surgery technician who infected at least 16 hospital patients with hepatitis C and may have exposed thousands more pleaded guilty to some charges Friday in an agreement that includes a 20-year prison term. Kristen Diane Parker, 26, had pleaded not guilty to the 42-count ...

LONDON (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Bayer's drug Nexavar for treating liver cancer on the state health service, despite a revised charging scheme from the company. Wednesday's decision is a setback for Bayer and its partner Onyx Pharmaceuticals, which have already seen Nexavar turned down by the National Institute of Health and Clinical Excellence ...

WASHINGTON (Reuters) - U.S. health officials are reviewing reports of liver injury in people who took Roche Holding AG's weight loss drug Xenical or the over-the-counter version sold by GlaxoSmithKline. The Food and Drug Administration said on Monday it had received 32 reports between 1999 and 2008 of serious liver injury in patients taking the drug, which is known ...

The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency. Regulators said Monday they have received more than 30 reports of liver damage in patients taking alli and Xenical, the prescription ...